ASSOCIATION OF DIFFERENT ETIOLOGICAL FACTORS AMONG PATIENTS WITH IDIOPATHIC ACQUIRED APLASTIC ANEMIA

H QAMAR; M JAVED; MD BASHEER; QA SHAH; TA SHAIKH; MK LUHANO

doi:10.54112/bcsrj.v2023i1.596

Authors

H QAMAR Department of Hematology, Poonch Medical College Rawalakot, Pakistan
M JAVED Rashid Latif Medical College, Lahore, Punjab, Pakistan
MD BASHEER THQ Hospital, Mang Shudhnoti AJK, Pakistan
QA SHAH Department of Medicine, Mayo Hospital, Lahore, Pakistan
TA SHAIKH Department of Pathology, Liaquat University of Medical and Health Sciences Jamshoro, Pakistan
MK LUHANO Liaquat University of Medical and Health Sciences Jamshoro, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.596

Keywords:

Idiopathic Aplastic Anemia, Pallor, Risk Factors

Abstract

A descriptive study was conducted at multiple centers, including Rashid Latif Medical College and Mayo Hospital in Lahore, from September 2022 to September 2023. The study aimed to determine the potential causes associated with idiopathic acquired aplastic anemia. The study included 55 patients with idiopathic acquired aplastic anemia. The patients were mainly between 18 and 35, with male patients being more prevalent. The etiological factors of aplastic anemia were assessed, and the results indicated that chronic liver disease affected 3 (5.5%) patients, drugs affected 2 (3.6%) patients, tuberculosis affected 3 (5.5%) patients, and pregnancy affected 1 (1.8%) patient. In conclusion, the study found that the most common etiological factors of idiopathic acquired aplastic anemia were chronic liver disease, drugs, tuberculosis, and pregnancy.

Downloads

Download data is not yet available.

References

Adil, S., Kakepoto, G., Khurshid, M., and Burney, I. (2001). Epidemiological features of aplastic anaemia in Pakistan. Journal of Pakistan Medical Association 51, 443.

Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., and Vardiman, J. W. (2016). The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood, The Journal of the American Society of Hematology 127, 2391-2405.

Belingheri, M., Fustinoni, S., De Vito, G., Porro, A., and Riva, M. A. (2019). Benzene and leukemia: from scientific evidence to regulations. A historical example. La Medicina del Lavoro 110, 234.

dos Santos Brito Silva Furtado, M., Borato Viana, M., Silqueira Hickson Rrios, J., Laís Lima Gontijo, R., Maria Silva, C., do Val Rezende, P., de Figueiredo, R. M., and Martins, M. L. (2016). Prevalence and incidence of erythrovirus B19 infection in children with sickle cell disease: the impact of viral infection in acute clinical events. Journal of Medical Virology 88, 588-595.

Ehsan, A., Shah, S. A. R., and Ibrahim, T. (2011). Epidemiology of acquired aplastic anaemia in Pakistan. Journal of Ayub Medical College Abbottabad 23, 102-105.

Gonzalez‐Casas, R., Garcia‐Buey, L., Jones, E., Gisbert, J., and Moreno‐Otero, R. (2009). Systematic review: hepatitis‐associated aplastic anaemia–a syndrome associated with abnormal immunological function. Alimentary pharmacology & therapeutics 30, 436-443.

Gupta, V., Tripathi, S., Singh, T., Tilak, V., and Bhatia, B. (2008). A study of bone marrow failure syndrome in children. Indian Journal of Medical Sciences 62, 13-18.

Javan, M. R., Saki, N., and Moghimian‐Boroujeni, B. (2021). Aplastic anemia, cellular and molecular aspects. Cell Biology International 45, 2395-2402.

Keel, S. B., Scott, A., Sanchez-Bonilla, M., Ho, P. A., Gulsuner, S., Pritchard, C. C., Abkowitz, J. L., King, M.-C., Walsh, T., and Shimamura, A. (2016). Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients. Haematologica 101, 1343.

Killick, S. B., Bown, N., Cavenagh, J., Dokal, I., Foukaneli, T., Hill, A., Hillmen, P., Ireland, R., Kulasekararaj, A., and Mufti, G. (2016). Guidelines for the diagnosis and management of adult aplastic anaemia. British journal of haematology 172, 187-207.

Liu, B., Shao, Y., Liu, Z., Liu, C., Zhang, T., and Fu, R. (2020). Bone marrow plasma cytokine signature profiles in severe aplastic anemia. BioMed Research International 2020.

Liu, C., Sun, Y., and Shao, Z. (2019). Current concepts of the pathogenesis of aplastic anemia. Current pharmaceutical design 25, 236-241.

Loomis, D., Guyton, K. Z., Grosse, Y., El Ghissassi, F., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Vilahur, N., Mattock, H., and Straif, K. (2017). Carcinogenicity of benzene. The Lancet Oncology 18, 1574-1575.

Luzzatto, L., and Risitano, A. M. (2018). Advances in understanding the pathogenesis of acquired aplastic anaemia. British Journal of Haematology 182, 758-776.

Nakao, S., and Gale, R. (2016). Are mild/moderate acquired idiopathic aplastic anaemia and low-risk myelodysplastic syndrome one or two diseases or both and how should it/they be treated? Leukemia 30, 2127-2130.

Peffault de Latour, R., Kulasekararaj, A., Iacobelli, S., Terwel, S. R., Cook, R., Griffin, M., Halkes, C. J., Recher, C., Barraco, F., and Forcade, E. (2022). Eltrombopag added to immunosuppression in severe aplastic anemia. New England Journal of Medicine 386, 11-23.

Rathore, S., Pramanick, A., Regi, A., and Lionel, J. (2014). Aplastic anemia in pregnancy. The Journal of Obstetrics and Gynecology of India 64, 26-28.

Schoettler, M. L., and Nathan, D. G. (2018). The pathophysiology of acquired aplastic anemia: current concepts revisited. Hematology/Oncology Clinics 32, 581-594.

Shimamura, A. (2016). Aplastic anemia and clonal evolution: germ line and somatic genetics. Hematology 2014, the American Society of Hematology Education Program Book 2016, 74-82.

Solimando, A. G., Palumbo, C., Pragnell, M. V., Bittrich, M., Argentiero, A., and Krebs, M. (2022). Aplastic anemia as a roadmap for bone marrow failure: an overview and a clinical workflow. International Journal of Molecular Sciences 23, 11765.